Healwell AI Statistics
Total Valuation
Healwell AI has a market cap or net worth of EUR 253.65 million. The enterprise value is 302.57 million.
| Market Cap | 253.65M |
| Enterprise Value | 302.57M |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 278.40M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +120.20% |
| Shares Change (QoQ) | +54.08% |
| Owned by Insiders (%) | 13.59% |
| Owned by Institutions (%) | 1.66% |
| Float | 143.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.86 |
| PB Ratio | 2.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.86 |
| EV / Sales | 5.88 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -25.07 |
Financial Position
The company has a current ratio of 0.69, with a Debt / Equity ratio of 0.60.
| Current Ratio | 0.69 |
| Quick Ratio | 0.60 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.60 |
| Interest Coverage | -12.33 |
Financial Efficiency
Return on equity (ROE) is -39.62% and return on invested capital (ROIC) is -16.28%.
| Return on Equity (ROE) | -39.62% |
| Return on Assets (ROA) | -12.22% |
| Return on Invested Capital (ROIC) | -16.28% |
| Return on Capital Employed (ROCE) | -17.75% |
| Revenue Per Employee | 149,042 |
| Profits Per Employee | -72,918 |
| Employee Count | 350 |
| Asset Turnover | 0.39 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.22M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.06% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +5.06% |
| 50-Day Moving Average | 0.84 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 48.42 |
| Average Volume (20 Days) | 9,579 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healwell AI had revenue of EUR 52.16 million and -25.52 million in losses. Loss per share was -0.13.
| Revenue | 52.16M |
| Gross Profit | 25.38M |
| Operating Income | -25.95M |
| Pretax Income | -27.39M |
| Net Income | -25.52M |
| EBITDA | -24.41M |
| EBIT | -25.95M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 11.91 million in cash and 55.56 million in debt, giving a net cash position of -43.66 million.
| Cash & Cash Equivalents | 11.91M |
| Total Debt | 55.56M |
| Net Cash | -43.66M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 92.62M |
| Book Value Per Share | 0.33 |
| Working Capital | -18.91M |
Cash Flow
In the last 12 months, operating cash flow was -11.84 million and capital expenditures -230,378, giving a free cash flow of -12.07 million.
| Operating Cash Flow | -11.84M |
| Capital Expenditures | -230,378 |
| Free Cash Flow | -12.07M |
| FCF Per Share | n/a |
Margins
Gross margin is 48.66%, with operating and profit margins of -49.74% and -48.92%.
| Gross Margin | 48.66% |
| Operating Margin | -49.74% |
| Pretax Margin | -52.50% |
| Profit Margin | -48.92% |
| EBITDA Margin | -46.80% |
| EBIT Margin | -49.74% |
| FCF Margin | n/a |
Dividends & Yields
Healwell AI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -120.20% |
| Shareholder Yield | -120.20% |
| Earnings Yield | -10.06% |
| FCF Yield | -4.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healwell AI has an Altman Z-Score of 0.24 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.24 |
| Piotroski F-Score | 3 |